Literature DB >> 21677405

Association of DDAH2 gene polymorphism with cardiovascular disease in Egyptian patients.

Mohamed Z Gad1, Sally I Hassanein, Sahar M Abdel-Maksoud, Gamal M Shaban, Khaled Abou-Aisha.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21677405     DOI： 10.1007/s12041-011-0043-4

Source DB:  PubMed          Journal:  J Genet        ISSN： 0022-1333            Impact factor:   1.166


× No keyword cloud information.
  12 in total

1.  Isoform-specific regulation by N(G),N(G)-dimethylarginine dimethylaminohydrolase of rat serum asymmetric dimethylarginine and vascular endothelium-derived relaxing factor/NO.

Authors:  Dan Wang; Pritmohinder S Gill; Tinatin Chabrashvili; Maristela L Onozato; Julie Raggio; Margarida Mendonca; Kathryn Dennehy; Min Li; Paul Modlinger; James Leiper; Patrick Vallance; Oscar Adler; Anna Leone; Akihiro Tojo; William J Welch; Christopher S Wilcox
Journal:  Circ Res       Date:  2007-08-02       Impact factor: 17.367

Review 2.  Genetic regulation of endothelial function.

Authors:  L C Jones; A D Hingorani
Journal:  Heart       Date:  2005-10       Impact factor: 5.994

3.  Efficient priming of PCR with short oligonucleotides conjugated to a minor groove binder.

Authors:  I Afonina; M Zivarts; I Kutyavin; E Lukhtanov; H Gamper; R B Meyer
Journal:  Nucleic Acids Res       Date:  1997-07-01       Impact factor: 16.971

4.  Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases.

Authors:  J M Leiper; J Santa Maria; A Chubb; R J MacAllister; I G Charles; G S Whitley; P Vallance
Journal:  Biochem J       Date:  1999-10-01       Impact factor: 3.857

5.  Polymorphisms in the promoter region of the dimethylarginine dimethylaminohydrolase 2 gene are associated with prevalence of hypertension.

Authors:  Renke Maas; Jeanette Erdmann; Nicole Lüneburg; Jan Stritzke; Edzard Schwedhelm; Christa Meisinger; Annette Peters; Joachim Weil; Heribert Schunkert; Rainer H Böger; Wolfgang Lieb
Journal:  Pharmacol Res       Date:  2009-08-08       Impact factor: 7.658

6.  Chromosomal localization, gene structure, and expression pattern of DDAH1: comparison with DDAH2 and implications for evolutionary origins.

Authors:  C T Tran; M F Fox; P Vallance; J M Leiper
Journal:  Genomics       Date:  2000-08-15       Impact factor: 5.736

7.  Common genetic variation in a basal promoter element alters DDAH2 expression in endothelial cells.

Authors:  L C Jones; C T L Tran; J M Leiper; A D Hingorani; P Vallance
Journal:  Biochem Biophys Res Commun       Date:  2003-10-24       Impact factor: 3.575

8.  Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence.

Authors:  Hayan Dayoub; Vinod Achan; Shanthi Adimoolam; Johannes Jacobi; Marcus C Stuehlinger; Bing-yin Wang; Philip S Tsao; M Kimoto; Patrick Vallance; Andrew J Patterson; John P Cooke
Journal:  Circulation       Date:  2003-11-24       Impact factor: 29.690

Review 9.  Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the "L-arginine paradox" and acts as a novel cardiovascular risk factor.

Authors:  Rainer H Böger
Journal:  J Nutr       Date:  2004-10       Impact factor: 4.798

10.  Septic shock is correlated with asymmetrical dimethyl arginine levels, which may be influenced by a polymorphism in the dimethylarginine dimethylaminohydrolase II gene: a prospective observational study.

Authors:  Michael J O'Dwyer; Felicity Dempsey; Vivion Crowley; Dermot P Kelleher; Ross McManus; Thomas Ryan
Journal:  Crit Care       Date:  2006       Impact factor: 9.097
View more
  1 in total

1.  Dimethylarginine Dimethylaminohydrolase 2 (DDAH 2) Gene Polymorphism, Asymmetric Dimethylarginine (ADMA) Concentrations, and Risk of Coronary Artery Disease: A Case-Control Study.

Authors:  Chao Xuan; Long-Qiang Xu; Qing-Wu Tian; Hui Li; Qing Wang; Guo-Wei He; Li-Min Lun
Journal:  Sci Rep       Date:  2016-09-28       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.